During the past decade, Unilever R&D Vlaardingen conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Unilever R&D Vlaardingen" #1 collaborator was "Top Institute Food and Nutrition" with 1 trials as a collaborator and "University of Edinburgh" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Unilever R&D Vlaardingen" are "Appetite Regulation" (1 trials), "Elevated Blood Pressure" (1 trials) and "Endothelial Dysfunction" (1 trials). Many other conditions were trialed in "Unilever R&D Vlaardingen" in a lesser frequency.

Most popular intervention types in "Unilever R&D Vlaardingen" are "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Grape seed extract" (1 trials), "Microcrystalline cellulose (placebo)" (1 trials) and "beta-glucan and fructooligosaccharide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Unilever R&D Vlaardingen" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Unilever R&D Vlaardingen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Unilever R&D Vlaardingen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Unilever R&D Vlaardingen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".